Press-release for stocks publishing date 2022 - 11

Prices are updated after-hours

publishing date : 2022 - 11 - 01 source : Www.biospace.com

save search

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS
Published: 2022-11-01 (Crawled : 23:00) - biospace.com/
CPIX | $1.65 5.1% 6.02% 1.4K

Health Technology

| -36.59% | O: -5.6% H: 9.38% C: 8.99%
pharmaceuticals financial results

Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines
Published: 2022-11-01 (Crawled : 23:00) - biospace.com/
EBS | $1.86 -2.11% -3.23% 770K

Health Technology

| -91.08% | O: 1.87% H: 1.46% C: -1.55%
candidate vaccine study chikungunya

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
CRSP M | $56.16 1.08% 1.03% 1.6M

Health Technology

| 10.74% | O: 2.81% H: 0.63% C: -3.33%
crispr therapeutics financial update results

TFF Pharmaceuticals Announces Second Patient Successfully Treated with Voriconazole Inhalation Powder Through Compassionate Use Program
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
TFFP | $3.135 -3.26% -9.69% 26K

Health Technology

| 29.6% | O: 0.8% H: 7.94% C: 7.14%
pharmaceuticals program

McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
MCK | $518.81 -1.35% 0.22% 630K

Distribution Services

| 35.07% | O: -0.35% H: 0.41% C: -1.54%
corporation results

Heron Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
HRTX | $2.71 -2.17% -2.21% 1.7M

Health Technology

| -28.05% | O: 2.08% H: 3.82% C: -1.02%
report therapeutics financial results

Ligand Announces Completion of OmniAb Spin-Off
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 12.16% | O: 7.74% H: 0.17% C: 0.17%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| 5.59% | O: 0.23% H: 0.0% C: 0.0%
LGND | $72.52 -8.05% -8.62% 130K

Health Technology

| -10.02% | O: 0.0% H: 1.5% C: -3.47%

Rigel Announces Top-line Results from FOCUS Phase 3 Clinical Trial of Fostamatinib in High Risk Hospitalized COVID-19 Patients
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
RIGL | $1.05 -5.41% -4.72% 1.2M

Health Technology

| 44.11% | O: 5.0% H: 6.93% C: -1.54%
covid-19 risk trial results

Cocrystal Pharma Granted European Patent Covering Oral Antiviral Candidate CC-42344 in Combination with Another Antiviral Agent for the Treatment of Influenza
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
COCP | $1.495 4.55% -1.39% 5.1K

Health Technology

| -39.52% | O: 4.03% H: 0.78% C: -4.65%
cc-4234 treatment pharma patent candidate antiviral granted influenza cc-42344

Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Operational Highlights on November 8, 2022
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
NVAX | $3.89 0.26% 2.1M

Health Technology

| -82.53% | O: 2.92% H: 10.38% C: -4.01%
conference financial results

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
XENE | $40.31 -3.17% -3.15% 320K

Health Technology

| 13.84% | O: 1.18% H: 4.35% C: 0.32%
pharmaceuticals conference financial update results

First Round of Late-Breaking Clinical Trial Results Announced at VIVA22
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SRDX | $26.39 -0.49% -0.57% 140K

Health Technology

| -22.32% | O: -0.21% H: 0.76% C: -0.26%
viva22 trial results

LianBio Doses First Patient in Registrational Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
LIAN | $4.92 0.41% 0.41% 410K

Professional, Scientific, and T...

| 237.24% | O: 3.45% H: 4.67% C: -5.33%
TARS | $32.85 -4.56% -4.65% 320K

Health Technology

| 86.86% | O: 1.19% H: 0.0% C: -3.86%
tp-03 chinese trial

Arbutus Presents AB-729 Clinical Data and AB-101 Preclinical Data at AASLD - The Liver Meeting®
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
ASMB | $13.33 3.17% 0.23% 17K

Health Technology

| 785.37% | O: 2.44% H: 1.19% C: -1.79%
ABUS | News | $2.73 -1.8% -1.83% 1M

Health Technology

| 17.52% | O: 0.85% H: 4.24% C: 2.54%
ab-729 meeting liver preclinical ab-101

Ambrx Biopharma Inc. Appoints Daniel O’Connor as Chief Executive Officer
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M

Professional, Scientific, and T...

| 2765.92% | O: -1.5% H: 2.63% C: -5.95%
ADXS | $0.57 -11.7% 12.48% 0

Health Technology

| -69.35% | O: 4.84% H: 0.0% C: -4.62%
biopharma

Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
ANEB | $2.85 -5.0% -7.14% 4.9K

Manufacturing

| 22.82% | O: 12.86% H: 6.62% C: 6.62%
pharmaceuticals

Eloxx Pharmaceuticals Announces Opening of Clinical Trial Sites for Phase 2 Study of ELX-02 for the Treatment of Alport SyndromeTrial sites now open in Australia and the United Kingdom
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
ELOX | $0.94 -2.34% -51.57% 93K

Health Technology

| -83.7% | O: 7.0% H: 2.4% C: -3.76%
elx-02 treatment pharmaceuticals australia trial study

Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022
Published: 2022-11-01 (Crawled : 21:00) - biospace.com/
STTK | $10.13 1.1% 0.89% 420K

Health Technology

| 278.11% | O: 4.15% H: 7.61% C: 0.36%
report financial results

Natera to Participate in Credit Suisse 31st Annual Healthcare Conference
Published: 2022-11-01 (Crawled : 20:00) - biospace.com/
NTRA S | $87.28 -3.38% -3.6% 1.2M

Health Services

| 92.36% | O: 1.41% H: 1.07% C: -1.99%
conference

Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
Published: 2022-11-01 (Crawled : 20:00) - biospace.com/
A | $132.44 -1.57% 0.0% 1.6M

Health Technology